Statins and type 2 diabetes . . . and other storiesBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3385 (Published 24 June 2016) Cite this as: BMJ 2016;353:i3385
Statins for all type 2 diabetes?
It used to be so easy. The Quality and Outcomes Framework command was issued, and party commissars presented every patient with diabetes with a Mao suit made of a statin and a couple of other drugs. Disobedience was punished by fines and disgrace. But “type 2 diabetes” is a risk state that differs for each person, and an analysis of data from three statin trials with large numbers of people with type 2 diabetes has been used to create and validate an absolute risk reduction score that can be used for individual patients (Circoutcomes doi:10.1161/CIRCOUTCOMES.115.001980). Risk levels vary widely. Shared decision making needs to replace the one-Mao-suit-fits-all model.
AUDAKUT stands for antenatal ultrasound diagnosed anomalies of the kidney and urinary tract. A study of more …